ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global TB Vaccine Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-10H5924
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global TB Vaccine Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global TB Vaccine Treatment Market Research Report 2025

Code: QYRE-Auto-10H5924
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals

TB Vaccine Treatment Market Size

The global market for TB Vaccine Treatment was valued at US$ 75.9 million in the year 2024 and is projected to reach a revised size of US$ 92.5 million by 2031, growing at a CAGR of 2.9% during the forecast period.

TB Vaccine Treatment Market

TB Vaccine Treatment Market

TB Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for TB Vaccine Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Vaccine Treatment.
The TB Vaccine Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TB Vaccine Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TB Vaccine Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of TB Vaccine Treatment Market Report

Report Metric Details
Report Name TB Vaccine Treatment Market
Accounted market size in year US$ 75.9 million
Forecasted market size in 2031 US$ 92.5 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Self-Procurement
  • UNICEF
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of TB Vaccine Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of TB Vaccine Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is TB Vaccine Treatment Market growing?

Ans: The TB Vaccine Treatment Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the TB Vaccine Treatment Market size in 2031?

Ans: The TB Vaccine Treatment Market size in 2031 will be US$ 92.5 million.

Who are the main players in the TB Vaccine Treatment Market report?

Ans: The main players in the TB Vaccine Treatment Market are Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals

What are the Application segmentation covered in the TB Vaccine Treatment Market report?

Ans: The Applications covered in the TB Vaccine Treatment Market report are Self-Procurement, UNICEF, Other

What are the Type segmentation covered in the TB Vaccine Treatment Market report?

Ans: The Types covered in the TB Vaccine Treatment Market report are Immune Vaccine, Therapy Vaccine

Recommended Reports

Vaccine Markets

Flu & Viral Vaccines

Emerging Vaccine Trends

1 TB Vaccine Treatment Market Overview
1.1 Product Definition
1.2 TB Vaccine Treatment by Type
1.2.1 Global TB Vaccine Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 TB Vaccine Treatment by Application
1.3.1 Global TB Vaccine Treatment Market Value by Application (2024 VS 2031)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global TB Vaccine Treatment Market Size Estimates and Forecasts
1.4.1 Global TB Vaccine Treatment Revenue 2020-2031
1.4.2 Global TB Vaccine Treatment Sales 2020-2031
1.4.3 Global TB Vaccine Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 TB Vaccine Treatment Market Competition by Manufacturers
2.1 Global TB Vaccine Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global TB Vaccine Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global TB Vaccine Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of TB Vaccine Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of TB Vaccine Treatment, Product Type & Application
2.7 Global Key Manufacturers of TB Vaccine Treatment, Date of Enter into This Industry
2.8 Global TB Vaccine Treatment Market Competitive Situation and Trends
2.8.1 Global TB Vaccine Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest TB Vaccine Treatment Players Market Share by Revenue
2.8.3 Global TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global TB Vaccine Treatment Market Scenario by Region
3.1 Global TB Vaccine Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global TB Vaccine Treatment Sales by Region: 2020-2031
3.2.1 Global TB Vaccine Treatment Sales by Region: 2020-2025
3.2.2 Global TB Vaccine Treatment Sales by Region: 2026-2031
3.3 Global TB Vaccine Treatment Revenue by Region: 2020-2031
3.3.1 Global TB Vaccine Treatment Revenue by Region: 2020-2025
3.3.2 Global TB Vaccine Treatment Revenue by Region: 2026-2031
3.4 North America TB Vaccine Treatment Market Facts & Figures by Country
3.4.1 North America TB Vaccine Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America TB Vaccine Treatment Sales by Country (2020-2031)
3.4.3 North America TB Vaccine Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe TB Vaccine Treatment Market Facts & Figures by Country
3.5.1 Europe TB Vaccine Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe TB Vaccine Treatment Sales by Country (2020-2031)
3.5.3 Europe TB Vaccine Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TB Vaccine Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific TB Vaccine Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific TB Vaccine Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific TB Vaccine Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America TB Vaccine Treatment Market Facts & Figures by Country
3.7.1 Latin America TB Vaccine Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America TB Vaccine Treatment Sales by Country (2020-2031)
3.7.3 Latin America TB Vaccine Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa TB Vaccine Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa TB Vaccine Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa TB Vaccine Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa TB Vaccine Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global TB Vaccine Treatment Sales by Type (2020-2031)
4.1.1 Global TB Vaccine Treatment Sales by Type (2020-2025)
4.1.2 Global TB Vaccine Treatment Sales by Type (2026-2031)
4.1.3 Global TB Vaccine Treatment Sales Market Share by Type (2020-2031)
4.2 Global TB Vaccine Treatment Revenue by Type (2020-2031)
4.2.1 Global TB Vaccine Treatment Revenue by Type (2020-2025)
4.2.2 Global TB Vaccine Treatment Revenue by Type (2026-2031)
4.2.3 Global TB Vaccine Treatment Revenue Market Share by Type (2020-2031)
4.3 Global TB Vaccine Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global TB Vaccine Treatment Sales by Application (2020-2031)
5.1.1 Global TB Vaccine Treatment Sales by Application (2020-2025)
5.1.2 Global TB Vaccine Treatment Sales by Application (2026-2031)
5.1.3 Global TB Vaccine Treatment Sales Market Share by Application (2020-2031)
5.2 Global TB Vaccine Treatment Revenue by Application (2020-2031)
5.2.1 Global TB Vaccine Treatment Revenue by Application (2020-2025)
5.2.2 Global TB Vaccine Treatment Revenue by Application (2026-2031)
5.2.3 Global TB Vaccine Treatment Revenue Market Share by Application (2020-2031)
5.3 Global TB Vaccine Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck TB Vaccine Treatment Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Japan BCG Lab TB Vaccine Treatment Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Company Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum Institute of India TB Vaccine Treatment Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AJ Vaccines TB Vaccine Treatment Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Company Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioFarma TB Vaccine Treatment Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Company Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GreenSignal Bio Pharma TB Vaccine Treatment Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.7.1 China National Biotec Company Information
6.7.2 China National Biotec Description and Business Overview
6.7.3 China National Biotec TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China National Biotec TB Vaccine Treatment Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomed Lublin TB Vaccine Treatment Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals TB Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals TB Vaccine Treatment Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TB Vaccine Treatment Industry Chain Analysis
7.2 TB Vaccine Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TB Vaccine Treatment Production Mode & Process Analysis
7.4 TB Vaccine Treatment Sales and Marketing
7.4.1 TB Vaccine Treatment Sales Channels
7.4.2 TB Vaccine Treatment Distributors
7.5 TB Vaccine Treatment Customer Analysis
8 TB Vaccine Treatment Market Dynamics
8.1 TB Vaccine Treatment Industry Trends
8.2 TB Vaccine Treatment Market Drivers
8.3 TB Vaccine Treatment Market Challenges
8.4 TB Vaccine Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
List of Tables
 Table 1. Global TB Vaccine Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global TB Vaccine Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global TB Vaccine Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global TB Vaccine Treatment Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global TB Vaccine Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global TB Vaccine Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global TB Vaccine Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market TB Vaccine Treatment Average Price (US$/K Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of TB Vaccine Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of TB Vaccine Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of TB Vaccine Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global TB Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccine Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global TB Vaccine Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global TB Vaccine Treatment Sales by Region (2020-2025) & (K Dose)
 Table 18. Global TB Vaccine Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global TB Vaccine Treatment Sales by Region (2026-2031) & (K Dose)
 Table 20. Global TB Vaccine Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global TB Vaccine Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global TB Vaccine Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global TB Vaccine Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global TB Vaccine Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America TB Vaccine Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America TB Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
 Table 27. North America TB Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
 Table 28. North America TB Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America TB Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe TB Vaccine Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe TB Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe TB Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe TB Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe TB Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific TB Vaccine Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific TB Vaccine Treatment Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific TB Vaccine Treatment Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific TB Vaccine Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific TB Vaccine Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America TB Vaccine Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America TB Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America TB Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America TB Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America TB Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa TB Vaccine Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa TB Vaccine Treatment Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa TB Vaccine Treatment Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa TB Vaccine Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa TB Vaccine Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global TB Vaccine Treatment Sales (K Dose) by Type (2020-2025)
 Table 51. Global TB Vaccine Treatment Sales (K Dose) by Type (2026-2031)
 Table 52. Global TB Vaccine Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global TB Vaccine Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global TB Vaccine Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global TB Vaccine Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global TB Vaccine Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global TB Vaccine Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2020-2025)
 Table 59. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2026-2031)
 Table 60. Global TB Vaccine Treatment Sales (K Dose) by Application (2020-2025)
 Table 61. Global TB Vaccine Treatment Sales (K Dose) by Application (2026-2031)
 Table 62. Global TB Vaccine Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global TB Vaccine Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global TB Vaccine Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global TB Vaccine Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global TB Vaccine Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global TB Vaccine Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2020-2025)
 Table 69. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 73. Merck TB Vaccine Treatment Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Japan BCG Lab Company Information
 Table 76. Japan BCG Lab Description and Business Overview
 Table 77. Japan BCG Lab TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 78. Japan BCG Lab TB Vaccine Treatment Product
 Table 79. Japan BCG Lab Recent Developments/Updates
 Table 80. Serum Institute of India Company Information
 Table 81. Serum Institute of India Description and Business Overview
 Table 82. Serum Institute of India TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 83. Serum Institute of India TB Vaccine Treatment Product
 Table 84. Serum Institute of India Recent Developments/Updates
 Table 85. AJ Vaccines Company Information
 Table 86. AJ Vaccines Description and Business Overview
 Table 87. AJ Vaccines TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 88. AJ Vaccines TB Vaccine Treatment Product
 Table 89. AJ Vaccines Recent Developments/Updates
 Table 90. BioFarma Company Information
 Table 91. BioFarma Description and Business Overview
 Table 92. BioFarma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 93. BioFarma TB Vaccine Treatment Product
 Table 94. BioFarma Recent Developments/Updates
 Table 95. GreenSignal Bio Pharma Company Information
 Table 96. GreenSignal Bio Pharma Description and Business Overview
 Table 97. GreenSignal Bio Pharma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 98. GreenSignal Bio Pharma TB Vaccine Treatment Product
 Table 99. GreenSignal Bio Pharma Recent Developments/Updates
 Table 100. China National Biotec Company Information
 Table 101. China National Biotec Description and Business Overview
 Table 102. China National Biotec TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 103. China National Biotec TB Vaccine Treatment Product
 Table 104. China National Biotec Recent Developments/Updates
 Table 105. Biomed Lublin Company Information
 Table 106. Biomed Lublin Description and Business Overview
 Table 107. Biomed Lublin TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 108. Biomed Lublin TB Vaccine Treatment Product
 Table 109. Biomed Lublin Recent Developments/Updates
 Table 110. Taj Pharmaceuticals Company Information
 Table 111. Taj Pharmaceuticals Description and Business Overview
 Table 112. Taj Pharmaceuticals TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2020-2025)
 Table 113. Taj Pharmaceuticals TB Vaccine Treatment Product
 Table 114. Taj Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. TB Vaccine Treatment Distributors List
 Table 118. TB Vaccine Treatment Customers List
 Table 119. TB Vaccine Treatment Market Trends
 Table 120. TB Vaccine Treatment Market Drivers
 Table 121. TB Vaccine Treatment Market Challenges
 Table 122. TB Vaccine Treatment Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of TB Vaccine Treatment
 Figure 2. Global TB Vaccine Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global TB Vaccine Treatment Market Share by Type: 2024 & 2031
 Figure 4. Immune Vaccine Product Picture
 Figure 5. Therapy Vaccine Product Picture
 Figure 6. Global TB Vaccine Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global TB Vaccine Treatment Market Share by Application: 2024 & 2031
 Figure 8. Self-Procurement
 Figure 9. UNICEF
 Figure 10. Other
 Figure 11. Global TB Vaccine Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global TB Vaccine Treatment Market Size (2020-2031) & (US$ Million)
 Figure 13. Global TB Vaccine Treatment Sales (2020-2031) & (K Dose)
 Figure 14. Global TB Vaccine Treatment Average Price (US$/K Dose) & (2020-2031)
 Figure 15. TB Vaccine Treatment Report Years Considered
 Figure 16. TB Vaccine Treatment Sales Share by Manufacturers in 2024
 Figure 17. Global TB Vaccine Treatment Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest TB Vaccine Treatment Players: Market Share by Revenue in TB Vaccine Treatment in 2024
 Figure 19. TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global TB Vaccine Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America TB Vaccine Treatment Sales Market Share by Country (2020-2031)
 Figure 22. North America TB Vaccine Treatment Revenue Market Share by Country (2020-2031)
 Figure 23. United States TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe TB Vaccine Treatment Sales Market Share by Country (2020-2031)
 Figure 26. Europe TB Vaccine Treatment Revenue Market Share by Country (2020-2031)
 Figure 27. Germany TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific TB Vaccine Treatment Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific TB Vaccine Treatment Revenue Market Share by Region (2020-2031)
 Figure 34. China TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America TB Vaccine Treatment Sales Market Share by Country (2020-2031)
 Figure 44. Latin America TB Vaccine Treatment Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa TB Vaccine Treatment Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa TB Vaccine Treatment Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE TB Vaccine Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of TB Vaccine Treatment by Type (2020-2031)
 Figure 54. Global Revenue Market Share of TB Vaccine Treatment by Type (2020-2031)
 Figure 55. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2020-2031)
 Figure 56. Global Sales Market Share of TB Vaccine Treatment by Application (2020-2031)
 Figure 57. Global Revenue Market Share of TB Vaccine Treatment by Application (2020-2031)
 Figure 58. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2020-2031)
 Figure 59. TB Vaccine Treatment Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global BCG and Tuberculosis Vaccine Market Research Report 2025
Global Tuberculosis Vaccination Market Research Report 2025
Global BCG Vaccine Market Insights Forecast to 2030
Global BCG Vaccination Market Research Report 2025
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacille Calmette Guerin Vaccine Market Research Report 2024
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
Global TB Vaccines Market Insights Forecast to 2030
Global TB Disease Vaccine Market Research Report 2025
Global Tuberculosis Vaccines Market Research Report 2024
Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Tuberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis Vaccine for Vhildren Market Research Report 2024
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis TB Diagnostics Market Research Report 2025
Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions